EUVIMEDEUVIMED entdecken
Crossref

Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh

Mohammad Osman, Md. Amirul Islam, Md. Ameer Abbas Abdullah, Moushumi Islam Urmi, Sharmin Akhter, Jahanara Akter, Nishat Nayla Aurpa, Marjan Siddika Rupsa, Kazi Gias Uddin Ahmed, Reaz Mahmud

Cureus · 03.11.2026

DOI: 10.7759/cureus.119034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 03.11.2026. Verfasst von Mohammad Osman und 9 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Osman, M., Islam, M. A., Abdullah, M. A. A., Urmi, M. I., Akhter, S., Akter, J., Aurpa, N. N., Rupsa, M. S., Ahmed, K. G. U., & Mahmud, R. (2026). Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh. Cureus. https://doi.org/10.7759/cureus.119034

Vancouver

Osman M, Islam MA, Abdullah MAA, Urmi MI, Akhter S, Akter J, et al. Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh. Cureus. 2026. doi:10.7759/cureus.119034

BibTeX
@article{Osman2026,
  author = {Osman, Mohammad and Islam, Md. Amirul and Abdullah, Md. Ameer Abbas and Urmi, Moushumi Islam and Akhter, Sharmin and Akter, Jahanara and Aurpa, Nishat Nayla and Rupsa, Marjan Siddika and Ahmed, Kazi Gias Uddin and Mahmud, Reaz},
  title = {Seizure Control, Tolerability, and Direct Drug Cost of Lamotrigine Versus Carbamazepine in Adults With Focal Epilepsy in a Randomized Open-Label Trial in Bangladesh},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119034}
}
Kostenlos starten →